Skip to main content
. 2020 Aug 21;162(2):471–489. doi: 10.1097/j.pain.0000000000002053

Table 2.

Mean or median values (BCa 95% CI) of self-reported; sensory, autonomic, and motor; and neuropsychological secondary outcome measures at each time point (intention-to-treat analysis).

Measure Group Time point
RS1 RS2 RS3 RS4 LTFU1 LTFU2
Self-report questionnaires
 Pain
  Pain severity (Brief Pain Inventory[/10]) M PA 5.91 (5.17 to 6.58) 6.02 (5.28 to 6.71) 5.41 (4.50 to 6.26) 5.43 (4.55 to 6.24) 5.62 (4.69 to 6.48) 5.59 (4.69 to 6.41)
Sham 5.81 (5.02 to 6.50) 5.95 (5.12 to 6.78) 5.85 (5.04 to 6.65) 5.84 (4.82 to 6.74) 6.04 (5.12 to 6.80) 5.95 (5.07 to 6.73)
  Pain interference (Brief Pain Inventory[/10]) Mdn PA 6.71 (6.29 to 6.71) 6.43 (5.00 to 7.08) 5.29 (3.57 to 6.43) 5.57 (4.71 to 6.29) 6.00 (5.22 to 6.14) 5.86 (4.57 to 6.86)
Sham 5.79 (5.00 to 7.14) 5.86 (5.72 to 5.86) 5.57 (5.43 to 5.57) 5.64 (4.00 to 6.14) 5.50 (3.71 to 6.57) 5.72 (4.14 to 6.57)
  Neuropathic features of pain (Pain Detect Questionnaire[/38]) Mdn PA 26.00 (26.00 to 26.00) 25.00 (20.00 to 26.00) 24.00 (21.00 to 27.00) 24.00 (20.00 to 26.00) 26.00 (25.00 to 26.00) 26.00 (21.46 to 28.00)
Sham 23.50 (21.50 to 27.00) 24.00 (23.00 to 24.00) 23.50 (20.00 to 26.00) 22.50 (17.06 to 26.00) 23.00 (20.00 to 25.00) 22.50 (18.00 to 26.00)
 Body representation
  Bath CRPS Body Perception Disturbance Scale (/57) M PA 27.65 (22.83 to 32.34) 27.78 (24.00 to 31.22) 22.13 (17.88 to 26.44) 24.39 (20.48 to 28.57) 25.52 (21.78 to 29.30) 24.57 (20.91 to 28.44)
Sham 28.96 (23.96 to 33.76) 27.73 (21.98 to 33.92) 29.00 (23.00 to 35.36) 26.81 (20.92 to 33.61) 26.77 (21.48 to 32.68) 27.65 (22.53 to 33.28)
 Emotional functioning
  Fear of movement (Tampa Scale for Kinesiophobia[/68]) M PA 38.79 (35.45 to 41.95) 38.52 (35.02 to 41.73) 37.43 (34.26 to 40.50) 37.91 (34.70 to 41.17) 38.74 (35.33 to 41.95) 40.05 (36.22 to 43.71)
Sham 40.38 (37.17 to 43.35) 39.73 (36.43 to 42.81) 38.27 (34.90 to 41.45) 37.42 (34.00 to 40.71) 38.24 (34.97 to 41.56) 37.27 (33.45 to 40.79)
  Mood disturbance (Profile of Mood States[/229]) M PA 94.81 (79.96 to 109.93) 98.25 (82.66 to 113.93) 86.52 (71.16 to 100.10) 86.21 (73.85 to 99.00) 88.80 (74.42 to 103.51) 95.54 (73.56 to 117.95)
Sham 84.22 (70.94 to 98.08) 91.27 (76.05 to 106.01) 83.21 (68.95 to 96.96) 83.35 (68.76 to 97.56) 82.42 (68.05 to 96.53) 89.13 (70.81 to 106.31)
 Perceived improvement due to treatment
  Patients' Global Impression of Change (/7) Mdn PA 2.00 (2.00 to 4.00) 3.00 (3.00 to 3.00) 2.00 (2.00 to 4.00) 3.00 (2.00 to 3.00)
Sham 3.00 (1.00 to 4.00) 4.00 (3.00 to 4.00) 2.00 (2.00 to 3.00) 2.00 (1.00 to 4.00)
Clinical assessments
 Sensory functions
  Mechanical detection threshold ratio Mdn PA −0.04 (−0.43 to 0.38) −0.35 (−1.12 to 0.17) −0.44 (−0.84 to −0.06) −0.54 (−1.51 to −0.10)
Sham −0.30 (−1.37 to 0.24) −0.05 (−0.25 to 0.17) −0.14 (−0.91 to 0.30) −0.22 (−0.76 to 0.28)
  Mechanical pain threshold ratio Mdn PA 0.62 (0.06 to 0.69) 0.50 (0.43 to 0.56) 0.07 (−0.32 to 0.66) 0.50 (0.06 to 0.69)
Sham 0.57 (0.24 to 0.67) 0.56 (0.38 to 0.73) 0.50 (0.32 to 0.71) 0.43 (0.24 to 0.78)
  Allodynia (/100) Mdn PA 14.00 (5.76 to 26.67) 18.87 (4.67 to 30.89) 16.90 (6.00 to 26.17) 10.73 (2.87 to 18.26)
Sham 20.50 (9.00 to 33.83) 14.37 (6.47 to 25.03) 13.87 (6.47 to 46.47) 18.03 (7.33 to 33.33)
  Two-point discrimination threshold ratio Mdn PA −0.06 (−0.16 to 0.11) 0.00 (−0.08 to 0.13) −0.08 (−0.20 to 0.00) −0.04 (−0.21 to 0.03)
Sham 0.15 (−0.07 to 0.31) −0.13 (−0.25 to 0.10) −0.09 (−0.17 to 0.00) 0.05 (−0.30 to 0.22)
 Autonomic functions
  Absolute temperature difference (°C) Mdn PA 0.47 (0.27 to 1.40) 0.30 (0.14 to 0.68) 0.35 (0.20 to 0.73) 0.50 (0.17 to 1.17)
Sham 0.47 (0.30 to 0.78) 0.82 (0.53 to 1.07) 0.77 (0.43 to 1.05) 0.67 (0.40 to 1.00)
  Oedema difference (cm) M PA −0.01 (−0.42 to 0.43) −0.04 (−0.36 to 0.28) −0.19 (−0.58 to 0.21) −0.23 (−0.64 to 0.20)
Sham −0.11 (−0.51 to 0.34) −0.02 (−0.40 to 0.38) −0.12 (−0.52 to 0.30) 0.04 (−0.33 to 0.43)
 Motor functions
  Grip strength ratio Mdn PA 0.35 (0.17 to 0.39) 0.31 (0.25 to 0.44) 0.35 (0.30 to 0.46) 0.39 (0.30 to 0.46)
Sham 0.32 (0.20 to 0.65) 0.33 (0.18 to 0.58) 0.44 (0.26 to 0.60) 0.42 (0.23 to 0.60)
  Delta finger-to-palm distance ratio Mdn PA 0.70 (0.60 to 0.88) 0.67 (0.61 to 0.87) 0.73 (0.63 to 0.84) 0.79 (0.70 to 0.82)
Sham 0.69 (0.55 to 0.90) 0.72 (0.53 to 0.88) 0.79 (0.53 to 0.89) 0.77 (0.60 to 0.93)
Experimental tests of neuropsychological functions
 Visuospatial attention
  Temporal Order Judgement task (Point of Subjective Simultaneity [ms]) Mdn PA 0.16 (−13.82 to 9.02) −3.26 (−14.51 to 8.35) −1.00 (−8.65 to 9.71) 5.18 (−1.74 to 10.87)
Sham −0.05 (−7.40 to 7.06) −0.75 (−8.55 to 6.65) 1.17 (−6.16 to 7.33) −2.12 (−10.48 to 6.07)
  Landmark task (Point of Subjective Equality[°]) Mdn PA 0.04 (−0.20 to 0.28) 0.09 (−0.01 to 0.19) 0.03 (−0.09 to 0.40) −0.02 (−0.13 to 0.19)
Sham 0.06 (−0.07 to 0.21) 0.06 (−0.12 to 0.17) −0.05 (−0.09 to 0.10) 0.05 (−0.04 to 0.10)
  Grayscales task M PA 0.17 (−0.07 to 0.41) 0.12 (−0.11 to 0.34) 0.08 (−0.13 to 0.30) 0.11 (−0.12 to 0.34)
Sham 0.09 (−0.08 to 0.26) 0.12 (−0.08 to 0.32) 0.07 (−0.10 to 0.25) 0.14 (−0.06 to 0.31)
 Mental representation of space
  Mental Number Line Bisection task M PA −0.06 (−0.76 to 0.67) −0.10 (−0.73 to 0.54) 0.04 (−0.58 to 0.63) −0.06 (−0.55 to 0.42)
Sham 0.12 (−0.51 to 0.77) 0.24 (−0.50 to 0.99) 0.39 (−0.36 to 1.21) 0.31 (−0.34 to 0.99)
 Spatially defined motor function
  Directional hypokinesia, affected hand, index A (ms) Mdn PA −4.88 (−41.02 to 29.55) −2.23 (−40.87 to 16.76) −15.41 (−58.35 to −9.44) −21.93 (−40.85 to −9.44)
Sham −15.65 (−79.21 to 26.94) 21.51 (−21.38 to 56.06) −24.31 (−61.88 to −12.51) −12.26 (−47.44 to 16.73)
  Directional hypokinesia, affected hand, index B (ms) Mdn PA −37.53 (−90.19 to 16.61) −25.46 (−84.04 to 13.63) −48.49 (−80.33 to −22.88) 4.10 (−40.19 to 10.67)
Sham −40.43 (−48.52 to −21.96) −0.40 (−61.60 to 15.61) −8.19 (−48.87 to 13.72) 3.32 (−43.06 to 20.37)
  Directional hypokinesia, unaffected hand, index A (ms) Mdn PA 0.14 (−15.93 to 19.88) 10.28 (1.15 to 22.22) −6.76 (−19.29 to 13.43) −2.78 (−45.45 to 13.43)
Sham 5.57 (−24.54 to 26.03) −7.88 (−20.59 to 14.27) 6.88 (−15.63 to 18.92) 2.51 (−13.48 to 23.38)
  Directional hypokinesia, unaffected hand, index B (ms) Mdn PA 4.84 (−6.43 to 11.89) 9.41 (−17.73 to 25.19) −3.40 (−21.35 to 33.52) 7.43 (−26.43 to 38.21)
Sham −23.63 (−48.34 to 12.93) 9.18 (−12.92 to 28.54) 11.01 (−10.84 to 28.46) 16.47 (−2.91 to 26.35)
  Directional bradykinesia, affected hand, index A (ms) Mdn PA 97.95 (23.29 to 216.69) 64.71 (22.36 to 123.85) 46.11 (14.19 to 72.77) 52.74 (22.18 to 66.01)
Sham 3.73 (−32.67 to 67.35) 50.72 (−5.50 to 64.21) 31.79 (3.63 to 87.48) 41.09 (11.92 to 64.21)
  Directional bradykinesia, affected hand, index B (ms) Mdn PA −49.68 (−125.50 to −8.16) −180.86 (−235.79 to −16.96) −124.70 (−129.09 to −122.32) −78.67 (−115.85 to −42.31)
Sham −63.53 (−149.00 to −57.28) −103.18 (−170.48 to −54.09) −77.46 (−97.96 to −17.51) −75.60 (−99.62 to −48.41)
  Directional bradykinesia, unaffected hand, index A (ms) Mdn PA 48.80 (35.53 to 64.67) 69.36 (35.74 to 103.71) 79.01 (45.24 to 99.85) 79.78 (59.27 to 116.99)
Sham 86.46 (54.45 to 127.39) 69.84 (24.68 to 113.96) 84.79 (76.26 to 86.26) 48.80 (35.53 to 64.67)
  Directional bradykinesia, unaffected hand, index B (ms) Mdn PA 31.39 (−13.35 to 64.92) 69.35 (25.05 to 98.88) 36.70 (21.07 to 63.50) 20.37 (−13.72 to 66.72)
Sham −28.35 (−71.98 to 41.21) 3.34 (−39.16 to 44.61) 28.60 (6.71 to 53.45) 3.38 (−22.98 to 12.57)
 Body representation
  Hand laterality recognition, accuracy index (%) M PA −1.65 (−5.66 to 2.34) −2.26 (−5.68 to 1.43) 1.30 (−2.23 to 4.37) 1.57 (−2.70 to 6.00)
Sham 2.77 (−1.32 to 7.37) −1.77 (−5.83 to 2.21) 3.92 (0.19 to 7.72) 2.54 (−2.00 to 6.83)
  Hand laterality recognition, reaction time index (ms) M PA −97.74 (−268.99 to 70.43) −57.20 (−187.91 to 70.02) −37.44 (−155.06 to 78.98) −130.05 (−240.98 to −27.84)
Sham −236.04 (−448.24 to −65.14) −129.37 (−263.61 to 21.19) −28.65 (−173.14 to 95.70) 19.77 (−112.95 to 161.67)

BCa 95% CI, bootstrapped bias-corrected and accelerated 95% confidence interval; CRPS, complex regional pain syndrome; LTFU1 and LTFU2, long-term follow-ups 1 and 2; M, mean; Mdn, median; PA, prism adaptation treatment; RS1, RS2, RS3, and RS4, research sessions 1, 2, 3, and 4; Sham, sham treatment.